Covered recipient · General Payments record
MITCHELL V BRODEY
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$8,593.28
- Reported across 535 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $2,108.46 | 126 |
| Education | $61.23 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Gilead Sciences, Inc. | $367.03 | 20 |
| ABBVIE INC. | $268.63 | 20 |
| GlaxoSmithKline, LLC. | $195.02 | 15 |
| Novo Nordisk AS | $173.09 | 16 |
| Acerta Pharma LLC | $158.92 | 4 |
| ViiV Healthcare Company | $138.36 | 9 |
| Astellas Pharma US Inc | $130.64 | 4 |
| Janssen Pharmaceuticals, Inc | $91.52 | 5 |
| Amgen Inc. | $68.55 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $56.75 | 3 |
| PFIZER INC. | $46.27 | 3 |
| Ferring Pharmaceuticals Inc. | $42.70 | 2 |
| Indivior Inc. | $42.24 | 2 |
| Abbott Laboratories | $35.47 | 2 |
| INTUITIVE SURGICAL, INC. | $33.62 | 1 |
| Insmed, Inc. | $33.55 | 2 |
| Shionogi Inc | $30.78 | 2 |
| Theratechnologies Inc. | $29.53 | 1 |
| Collegium Pharmaceutical, Inc. | $29.06 | 2 |
| ALK-Abello, Inc | $27.85 | 1 |
| SHIELD THERAPEUTICS INC | $27.38 | 2 |
| Axsome Therapeutics, Inc. | $21.38 | 1 |
| Lilly USA, LLC | $20.11 | 1 |
| Otsuka America Pharmaceutical, Inc. | $19.39 | 1 |
| Exact Sciences Corporation | $18.99 | 1 |
| Cumberland Pharmaceuticals, Inc. | $18.29 | 1 |
| Merck Sharp & Dohme Corporation | $15.12 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $14.81 | 1 |
| Paratek Pharmaceuticals, Inc. | $14.64 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (128)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.